Prevention of Recurrent Preterm Delivery by a Natural Progesterone Agent

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To examine the preterm delivery rate of a preterm delivery high risk group of pregnant women, using once daily natural progesterone agent.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pregnancy Premature Birth

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Pre-term labor progesterone

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Crinone Gel 8%

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Pregnancy 24 weeks' gestation Preterm labor in previous pregnancies

\-

Exclusion Criteria

* No medications for PTL or any kind of progesterone.
* Cervical suture
* Multiple pregnancy

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yuri Perlitz, MD

Role: STUDY_CHAIR

The Baruch Padeh Medical Center, Poriya

Mosheh Ben Ami, Prof.

Role: PRINCIPAL_INVESTIGATOR

Head of Obs/Gyn ,The Baruch Padeh Medical center, Poriya

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PTL Progesterone Perlitz.CTIL

Identifier Type: -

Identifier Source: org_study_id